Home » Newsletters » BioWorld

BioWorld

June 24, 1992

View Archived Issues

BISPECIFIC ANTIBODY SHOWS PROMISE VS. HIV

TUESDAY'S STOCKS

CHIRON GETS PATENT TO PROBE TEST TECHNOLOGY

50-YEAR-OLD DRUG RELIEVES HEADACHE PAIN

CAMBRIDGE BIO TO BUY STAKE IN IMMUCELL

LIPOSOME CO. SAYS VESTAR INFRINGES PATENT

ALLELIX PLANS CLINICALS FOR HEART DRUG

AIS GETS NIH GRANT FOR GENE THERAPY

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...